PTC
BLUE

Private Trust Company’s bluebird bio BLUE Stock Holding History

Private Trust Company’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2
Closed -$1K – 400
2014
Q3 		$1K Hold
2
– – ﹤0.01% 1708
2014
Q2 		$1K Hold
2
– – ﹤0.01% 1730
2014
Q1 		$0 Hold
2
– – ﹤0.01% 1826
2013
Q4 		$0 Buy
+2
New +$559 ﹤0.01% 1766

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Private Trust Company's BLUE Position: Q4 2014 in Review

Private Trust Company sold out of bluebird bio (BLUE) in Q4 2014, closing a stake of 2 shares — an estimated $1K sold.

Private Trust Company first reported a position in BLUE in Q4 2013 and held it in 4 quarters. The position peaked at $1K in Q3 2014. 169 funds tracked by Wall St. Rank hold BLUE as of Q4 2014.

  • Private Trust Company reported no remaining bluebird bio position as of Q4 2014 after selling out during the quarter.
  • Private Trust Company sold 2 bluebird bio shares in Q4 2014, an estimated $1K.
  • Private Trust Company first reported a position in bluebird bio in Q4 2013 and held it in 4 quarters.
  • Private Trust Company's bluebird bio position peaked at $1K in Q3 2014.
  • 169 funds tracked by Wall St. Rank held bluebird bio as of Q4 2014.

Based on Private Trust Company's 13F filing for Q4 2014, filed 28 Jan 2015.